Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hartnup disease
Comorbidity C0038012|spondylitis
Sentences 3
PubMedID- 24286564 In earlier reports, mcii for eq-5d has been found to vary considerably (0–0.69) in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis after 3 months of treatment with disease-modifying anti-rheumatic drugs, indicating that mcii is dependent on patient group (kvamme et al.
PubMedID- 23297014 Il-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-tnf agents.
PubMedID- 24447112 Effect of tumour necrosis factor-alpha inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.

Page: 1